HighTide Therapeutics Inc

Company Profile

• Business description

  HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases.

• Contact

  Building D, Guangdong
  Floor 9 to 10, Fubao Community, Futian District
  Shenzhen-Hong Kong Science and
  Technology Innovation Cooperation Zone
  Shenzhen518112
  CHN

  T: +86 75526626253

  https://www.hightidetx.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2025

  Employees

  70